생물 안전 시험 제품 및 서비스 시장 규모, 점유율, 동향 및 성장 분석 보고서(2026-2034년)

The Biological Safety Testing Products And Services Market size is expected to reach USD 15.89 Billion in 2034 from USD 6.23 Billion (2025) growing at a CAGR of 10.97% during 2026-2034.

The global biological safety testing products and services market is experiencing significant growth due to the rising demand for safe biopharmaceutical products and vaccines. Regulatory authorities require strict safety testing for biologics, including vaccines, cell therapies, and monoclonal antibodies, which is driving the adoption of advanced testing services and products. Increasing research activities in biotechnology and the expansion of pharmaceutical manufacturing facilities are further supporting market expansion.

The market is also benefiting from the growing pipeline of biologics and biosimilars worldwide. As the number of biologic drugs entering clinical trials increases, the need for contamination testing, endotoxin testing, and sterility testing is rising. Technological advancements in rapid microbiological methods and automated testing solutions are improving testing accuracy and efficiency. Pharmaceutical and biotechnology companies are increasingly adopting innovative testing platforms to ensure product quality and regulatory compliance.

Looking ahead, the market is expected to witness robust growth as biologics and advanced therapies continue to dominate the pharmaceutical landscape. The expansion of contract research organizations and testing laboratories will further boost outsourcing trends. Moreover, emerging markets are investing heavily in pharmaceutical manufacturing infrastructure, creating new opportunities for biological safety testing services. Continuous innovation in testing technologies and stringent regulatory standards will remain key factors shaping future growth.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Product

• Reagents & Kits
• Instruments
• Services

By Application

• Vaccines & Therapeutics (Vaccines, Monoclonal Antibodies, Recombinant Protein)
• Blood & Blood-Based Products
• Gene Therapy
• Tissue & Tissue-Based Products
• Stem Cell

By Test Type

• Endotoxin Tests
• Sterility Tests
• Cell Line Authentication & Characterization Tests
• Bioburden Tests
• Adventitious Agent Detection Tests
• Residual Host Contamination Detection Tests
• Others

COMPANIES PROFILED

• Charles River Laboratories International, BSL Bioservice GmbH, Merck KGaA MilliporeSigma, Samsung Biologics Co Ltd, Sartorius AG, Eurofins Scientific SE, SGS Socit Gnrale de Surveillance SA, Thermo Fisher Scientific Inc, bioMrieux SA, Lonza Group AG
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL BIOLOGICAL SAFETY TESTING PRODUCTS AND SERVICES MARKET: BY PRODUCT 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Product
• 4.2. Reagents & Kits Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Instruments Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Services Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL BIOLOGICAL SAFETY TESTING PRODUCTS AND SERVICES MARKET: BY APPLICATION 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Application
• 5.2. Vaccines & Therapeutics (Vaccines, Monoclonal Antibodies, Recombinant Protein) Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Blood & Blood-Based Products Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Gene Therapy Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.5. Tissue & Tissue-Based Products Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.6. Stem Cell Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL BIOLOGICAL SAFETY TESTING PRODUCTS AND SERVICES MARKET: BY TEST TYPE 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast Test Type
• 6.2. Endotoxin Tests Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Sterility Tests Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Cell Line Authentication & Characterization Tests Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.5. Bioburden Tests Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.6. Adventitious Agent Detection Tests Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.7. Residual Host Contamination Detection Tests Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.8. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL BIOLOGICAL SAFETY TESTING PRODUCTS AND SERVICES MARKET: BY REGION 2022-2034(USD MN)

• 7.1. Regional Outlook
• 7.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.2.1 By Product
  • 7.2.2 By Application
  • 7.2.3 By Test Type
  • 7.2.4 United States
  • 7.2.5 Canada
  • 7.2.6 Mexico
• 7.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.3.1 By Product
  • 7.3.2 By Application
  • 7.3.3 By Test Type
  • 7.3.4 United Kingdom
  • 7.3.5 France
  • 7.3.6 Germany
  • 7.3.7 Italy
  • 7.3.8 Russia
  • 7.3.9 Rest Of Europe
• 7.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.4.1 By Product
  • 7.4.2 By Application
  • 7.4.3 By Test Type
  • 7.4.4 India
  • 7.4.5 Japan
  • 7.4.6 South Korea
  • 7.4.7 Australia
  • 7.4.8 South East Asia
  • 7.4.9 Rest Of Asia Pacific
• 7.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.5.1 By Product
  • 7.5.2 By Application
  • 7.5.3 By Test Type
  • 7.5.4 Brazil
  • 7.5.5 Argentina
  • 7.5.6 Peru
  • 7.5.7 Chile
  • 7.5.8 South East Asia
  • 7.5.9 Rest of Latin America
• 7.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.6.1 By Product
  • 7.6.2 By Application
  • 7.6.3 By Test Type
  • 7.6.4 Saudi Arabia
  • 7.6.5 UAE
  • 7.6.6 Israel
  • 7.6.7 South Africa
  • 7.6.8 Rest of the Middle East And Africa

Chapter 8. COMPETITIVE LANDSCAPE

• 8.1. Recent Developments
• 8.2. Company Categorization
• 8.3. Supply Chain & Channel Partners (based on availability)
• 8.4. Market Share & Positioning Analysis (based on availability)
• 8.5. Vendor Landscape (based on availability)
• 8.6. Strategy Mapping

Chapter 9. COMPANY PROFILES OF GLOBAL BIOLOGICAL SAFETY TESTING PRODUCTS AND SERVICES INDUSTRY

• 9.1. Top Companies Market Share Analysis
• 9.2. Company Profiles
  • 9.2.1 Charles River Laboratories International
  • 9.2.2 BSL Bioservice GmbH
  • 9.2.3 Merck KGaA (MilliporeSigma)
  • 9.2.4 Samsung Biologics Co. Ltd
  • 9.2.5 Sartorius AG
  • 9.2.6 Eurofins Scientific SE
  • 9.2.7 SGS SociAfA(C)TAfA(C) GAfA(C)NAfA(C)Rale De Surveillance SA
  • 9.2.8 Thermo Fisher Scientific Inc
  • 9.2.9 BioMAfA(C)Rieux SA
  • 9.2.10 Lonza Group AG